![Lab Owner Convicted for $463 Million Genetic Testing Fraud](https://www.g2intelligence.com/wp-content/uploads/2023/01/Feb23.NLR_.GeneticTestingKickbackCase-iStock-1800x1250-1-1080x675.jpg)
Lab Owner Convicted for $463 Million Genetic Testing Fraud
Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.
Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.
While most recent cases were the usual FCA and kickback-related issues, one involved the mischarging of federal grants by two biotech companies and their co-founder.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
Last week’s cases saw a major false claims-related settlement, as well as many kickback-related schemes.
The agency’s latest report to Congress shows that while enforcement activity is returning to pre-pandemic levels, recoveries are still down.